ProbioMed 50
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80087177
- Status
- Active licence
- Licence date
- 18 July 2018
- Revision date
- 13 January 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus casei Source : UALc-03 | 3.6 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : Cellule entière | 3.6 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 2.9 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : HN001 | 2.9 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : DDS-1 | 5.7 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 5.7 Milliards d'UFC | Not calculated |
| Ligilactobacillus salivarius Source : LS-33 | 2.9 Milliards d'UFC | Not calculated |
| Ligilactobacillus salivarius Source : UALs07 | 2.9 Milliards d'UFC | Not calculated |
| Ligilactobacillus salivarius Source : Cellule entière | 2.9 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : LPC-37 | 3 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : Cellule entière | 3 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Bb-03 | 3.5 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 3.5 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : UABbr11 | 3.5 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : UALP-05 | 8.6 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Cellule entière | 8.6 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : UABb10 | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Silice, Hydroxypropyl méthylcellulose, Cellulose microcristalline, Stéarate de magnésium, Gomme de gellane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 6 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of Probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80087177
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging